APA (7th ed.) Citation

Saad Alkhowaiter, Maha M. Al Rasheed, Nuha Alammar, Ammar Alotaibi, Mansour Altuwaijri, Suliman Alshankiti, . . . Majid Alsahafi. (2024). Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis. Elsevier.

Chicago Style (17th ed.) Citation

Saad Alkhowaiter, Maha M. Al Rasheed, Nuha Alammar, Ammar Alotaibi, Mansour Altuwaijri, Suliman Alshankiti, Mohammed A. Omair, and Majid Alsahafi. Safety of Prolonged Use of Metoclopramide and Domperidone as Treatment for Chronic Gastrointestinal Dysmotility Disorders in Patients with Systemic Sclerosis. Elsevier, 2024.

MLA (9th ed.) Citation

Saad Alkhowaiter, et al. Safety of Prolonged Use of Metoclopramide and Domperidone as Treatment for Chronic Gastrointestinal Dysmotility Disorders in Patients with Systemic Sclerosis. Elsevier, 2024.